These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9547857)

  • 21. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
    Gargosky SE; Tapanainen P; Rosenfeld RG
    Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of porcine growth hormone (pGH) binding to porcine liver microsomes: chronic administration of pGH induces pGH binding.
    Chung CS; Etherton TD
    Endocrinology; 1986 Aug; 119(2):780-6. PubMed ID: 3015557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of growth hormone on skeletal muscle. I. Studies on normal adult rats.
    Ullman M; Oldfors A
    Acta Physiol Scand; 1989 Apr; 135(4):531-6. PubMed ID: 2735197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone.
    Chrysis D; Underwood LE
    Endocrinology; 1999 Dec; 140(12):5635-41. PubMed ID: 10579327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant rat and mouse growth hormones: risk assessment of carcinogenic potential in 2-year bioassays in rats and mice.
    Farris GM; Miller GK; Wollenberg GK; Molon-Noblot S; Chan C; Prahalada S
    Toxicol Sci; 2007 Jun; 97(2):548-61. PubMed ID: 17372281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.
    Ge X; Yu J; Jiang H
    J Anim Sci; 2012 Apr; 90(4):1126-33. PubMed ID: 22100600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults.
    Woodhouse LJ; Asa SL; Thomas SG; Ezzat S
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4570-7. PubMed ID: 10599721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.
    Ferdinandi ES; Brazeau P; High K; Procter B; Fennell S; Dubreuil P
    Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):49-58. PubMed ID: 17214611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leptin expression in porcine adipose tissue is not increased by endotoxin but is reduced by growth hormone.
    Spurlock ME; Ranalletta MA; Cornelius SG; Frank GR; Willis GM; Ji S; Grant AL; Bidwell CA
    J Interferon Cytokine Res; 1998 Dec; 18(12):1051-8. PubMed ID: 9877449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
    Granado M; Martín AI; Villanúa MA; López-Calderón A
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.
    López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
    Growth Horm IGF Res; 2012 Feb; 22(1):22-9. PubMed ID: 22244673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of growth hormone on skeletal muscle.
    Weber MM
    Horm Res; 2002; 58 Suppl 3():43-8. PubMed ID: 12435897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential actions of growth hormone and insulin-like growth factor-I on tissue protein metabolism in dwarf mice.
    Pell JM; Bates PC
    Endocrinology; 1992 Apr; 130(4):1942-50. PubMed ID: 1547721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I.
    Brink M; Price SR; Chrast J; Bailey JL; Anwar A; Mitch WE; Delafontaine P
    Endocrinology; 2001 Apr; 142(4):1489-96. PubMed ID: 11250929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats.
    Inaba T; Saito H; Fukushima R; Hashiguchi Y; Lin MT; Inoue T; Fukatsu K; Muto T; Takenaka A; Takahashi S; Noguchi T
    JPEN J Parenter Enteral Nutr; 1996; 20(5):325-31. PubMed ID: 8887900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs.
    Draghia-Akli R; Cummings KK; Khan AS; Brown PA; Carpenter RH
    J Anim Sci; 2003 Sep; 81(9):2301-10. PubMed ID: 12968706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.